Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

April 16 2024 - J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales

J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales
Ukraine was pharma’s ‘darling’ of clinical trials. As war drags on, will the industry come back?
Humira biosimilar scripts take off
Intra-Cellular launches 26% to record high, breaking out after depression drug scores big
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Medicare Will Continue to Cover 2 Expensive Cancer Drugs

NY Times, NY

Friday, July 1, 2011 - 9:55am

tags:

Medicare, Provenge, prostate cancer, Dendreon, Roche, Avastin, breast cancer

Cramer Interviews Celgene CEO Hugin

CNBC

Friday, July 1, 2011 - 9:53am

tags:

Celgene, Pharma CEOs, Bob Hugin

Merck says Gardasil, Cubicin approved in Japan

Yahoo/AP

Friday, July 1, 2011 - 9:47am

tags:

Gardasil, Japan, Merck, Cubicin, Cubist Pharmaceuticals

3 Biotech Drugs With Promising Phase III Data, Moving Into FDA Review

Motley Fool

Friday, July 1, 2011 - 9:44am

tags:

FDA, Bristol-Myers Squibb, AstraZeneca, Pfizer, Incyte, Novartis, ruxolitinib, Apixaban, Dapagliflozin

Dendreon Wins Final Medicare Coverage Decision on Prostate Cancer Drug

Bloomberg

Thursday, June 30, 2011 - 7:34pm

tags:

prostate cancer, Dendreon, Provenge, Medicare

Change in Warner Chilcott's R&D

Yahoo/Zacks.com

Thursday, June 30, 2011 - 7:32pm

tags:

R&D, Warner Chilcott, P&G

6 Healthcare Companies With July Catalysts

Seeking Alpha

Thursday, June 30, 2011 - 7:26pm

tags:

Alexa, AstraZeneca, Bristol-Myers Squibb, JNJ, Seattle Genetics, Transcept

What Docs Think Of Pharma & Where They Get Info

Pharmalot

Thursday, June 30, 2011 - 4:39pm

tags:

Abbott’s Depakote, Generics Tied to Cognitive Risks, FDA Says

Bloomberg

Thursday, June 30, 2011 - 4:35pm

tags:

Abbott Laboratories, generics, Depakote

Johnson & Johnson/Gilead Deal Could Yield More Combinations in HIV

Seeking Alpha

Thursday, June 30, 2011 - 4:28pm

tags:

Pfizer, Merck, JNJ, HIV, GSK, Gilead Sciences, Bristol-Myers Squibb, Abbott Laboratories

What the Avastin Vote Means

Minyanville

Thursday, June 30, 2011 - 4:14pm

tags:

Avastin, breast cancer, Roche, FDA, advisory panels

The Big Bet on XOMA

Motley Fool

Thursday, June 30, 2011 - 4:08pm

tags:

Astellas' patent sale gins $609M for new round of dealmaking

Fierce Biotech

Thursday, June 30, 2011 - 9:36am

tags:

Astellas, patents, diabetes, OSI Pharmaceuticals

Forest/Almirall's COPD drug filed in USA

Pharma Times, UK

Thursday, June 30, 2011 - 9:35am

tags:

Forest Labs, Almirall, COPD, FDA, aclidinium

Congress Widens Probe Into The Heparin Scandal

Pharmalot

Thursday, June 30, 2011 - 9:34am

tags:

congress, Heparin, FDA, China

Corcept Therapeutics says FDA will make decision on Cushing's Syndrome drug Corlux by Feb. 17

Yahoo/AP

Thursday, June 30, 2011 - 9:31am

tags:

Corcept Therapeutics, FDA, Cushing's disease, Corlux

VIVUS Submits New Drug Application for Avanafil for the Treatment of Erectile Dysfunction

Yahoo

Thursday, June 30, 2011 - 8:18am

tags:

Vivus, Avanafil, erectile dysfunction

The Diabetes Trade: Why We Like Amylin

Seeking Alpha

Thursday, June 30, 2011 - 8:02am

tags:

diabetes, Amylin

BioCryst files for $70M shelf offering

Bizjournals.com

Thursday, June 30, 2011 - 7:47am

tags:

stock offering, Biocryst

Ziopharm: Small Molecules Meet Next-Generation Synthetic Biology

Seeking Alpha

Thursday, June 30, 2011 - 7:46am

tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition

Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sapio Sciences launches new drug discovery platform

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How Patient Engagement Can Reduce Brand Launch Risks

Drug Channels

The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead

Drug Channels

SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025

Drug Channels

Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)

Drug Channels

Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)

Drug Channels

The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)

Drug Channels

What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)

Drug Channels

Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s (rerun)

Drug Channels

Navigating Market Access Challenges in Life Sciences Commercialization

Drug Channels